Myelodysplastic Syndrome, Pyoderma Gangrenosum, and Crohn Disease

American Journal of Pediatric Hematology/Oncology

Volumn 23, Issue 4, 2001, Pages 259-260

  Sandoval, Claudio ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE;

CLINICAL ARTICLE; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; FEMALE; HUMAN; LETTER; MALE; MYELODYSPLASTIC SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; PYODERMA GANGRENOSUM; AGED; INFANT; NOTE;

AGED; CROHN DISEASE; FEMALE; HUMANS; INFANT; MALE; MYELODYSPLASTIC SYNDROMES; PYODERMA GANGRENOSUM;

EID: 0034743913     PISSN: 01928562     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043426-200105000-00021     Document Type: Letter

References (3)

1. Gümrük F, Tuncer MA, Hisönmez G. Pyoderma gangrenosum in a child with myelodysplastic syndrome. J Pediatr Hematol Oncol 2000; 22:362-4.
2. Bosch X, Bernadich O, Vera M. The association between Crohn disease and the myelodysplastic syndromes. Medicine (Baltimore) 1998; 77:371-7.
3. Mir-Madjlessi SH, Taylor JS, Farmer RG. Clinical course and evolution of erythema nodosum and pyoderma gangrenosum in chronic ulcerative colitis: a study of 42 patients. Am J Gastroenterol 1985; 80:615-20.